BioLineRx (BLRX) Invested Capital (2011 - 2026)
BioLineRx (BLRX) recorded Invested Capital of $23.32 million in the quarter ended Jun 30, 2026, down 25.4% from $31.27 million a year earlier and down 18.7% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Invested Capital (2011 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, BioLineRx reported Invested Capital of $32.28 million, up 20.0% from the prior year.
- Annual Invested Capital has a five-year compound annual growth rate of 3.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Invested Capital came in at $26.9 million in the year ended Dec 31, 2024 (+17.0%), $23 million in the year ended Dec 31, 2023 (-62.3%), $61.01 million in the year ended Dec 31, 2022 (-13.9%) and $70.84 million in the year ended Dec 31, 2021 (+154.3%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Invested Capital since the quarter ended Mar 31, 2024.
- On a year-over-year basis, Invested Capital rose in four of the last eight quarters, with growth averaging 5.6%.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 154.3% in the quarter ended Dec 31, 2021, against a decline of 62.3% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.67 million (quarter ended Mar 31, 2026), $32.28 million (quarter ended Dec 31, 2025) and $29.61 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | 23.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.32 Mn |
| Mar 31, 2026 | 28.67 Mn |
| Dec 31, 2025 | 32.28 Mn |
| Sep 30, 2025 | 29.61 Mn |
| Jun 30, 2025 | 31.27 Mn |
| Mar 31, 2025 | 33.18 Mn |
| Dec 31, 2024 | 26.90 Mn |
| Sep 30, 2024 | 36.31 Mn |
| Jun 30, 2024 | 43.43 Mn |
| Mar 31, 2024 | 22.68 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 24.67 Mn |
| Jun 30, 2023 | 32.63 Mn |
| Mar 31, 2023 | 49.91 Mn |
| Dec 31, 2022 | 61.01 Mn |
| Sep 30, 2022 | 64.68 Mn |
| Jun 30, 2022 | 57.58 Mn |
| Mar 31, 2022 | 65.32 Mn |
| Dec 31, 2021 | 70.84 Mn |
| Sep 30, 2021 | 74.48 Mn |
API Access
BioLineRx Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();